In the last trading session, 3.87 million Microbot Medical Inc (NASDAQ:MBOT) shares changed hands as the company’s beta touched 1.43. With the company’s per share price at $1.93 changed hands at $0.06 or 3.21% during last session, the market valuation stood at $46.79M. MBOT’s last price was a discount, traded about -75.13% off its 52-week high of $3.38. The share price had its 52-week low at $0.82, which suggests the last value was 57.51% up since then. When we look at Microbot Medical Inc’s average trading volume, we note the 10-day average is 12.12 million shares, with the 3-month average coming to 2.03 million.
Analysts gave the Microbot Medical Inc (MBOT) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.00. If we narrow down to specifics, the data shows that 0 out of 1 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended MBOT as a Hold, 1 felt it is a Buy and 0 rated the stock as Underweight. Microbot Medical Inc’s EPS for the current quarter is expected to be 0.
Microbot Medical Inc (NASDAQ:MBOT) trade information
Instantly MBOT was in green as seen at the end of in last trading. With action 69.30%, the performance over the past five days has been green. The company’s shares are showing year-to-date upside of 72.32%, with the 5-day performance at 69.30% in the green. However, in the 30-day time frame, Microbot Medical Inc (NASDAQ:MBOT) is 91.09% up. Looking at the short shares, we see there were 0.57 million shares sold at short interest cover period of 2.65 days.
Microbot Medical Inc (MBOT) estimates and forecasts
Data shows that the Microbot Medical Inc share is performing relatively much better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot 82.08% over the past 6 months, a 37.14% in annual growth rate that is considerably higher than the industry average of 14.90%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 15.28%.
MBOT Dividends
Microbot Medical Inc is expected to release its next quarterly earnings report in February.
Microbot Medical Inc (NASDAQ:MBOT)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 1.43% of Microbot Medical Inc shares while 7.46% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 7.57%. There are 7.46% institutions holding the Microbot Medical Inc stock share, with VANGUARD GROUP INC the top institutional holder. As of 2024-06-30, the company held 3.2694% of the shares, roughly 0.46 million MBOT shares worth $0.47 million.
BLACKROCK INC. holds the second largest percentage of outstanding shares, with 0.9773% or 0.14 million shares worth $0.14 million as of 2024-06-30.
Among Mutual Funds, the top two as of Sep 30, 2024 were Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund . With 348.55 shares estimated at $0.67 million under it, the former controlled 1.72% of total outstanding shares. On the other hand, Vanguard Extended Market Index Fund held about 0.53% of the shares, roughly 108.03 shares worth around $0.21 million.
